CLOSURE OF TRADING WINDOW
Awaiting price reaction for this filing.
Citurgia Biochemicals has announced the closure of its trading window starting 1st July 2026, in compliance with SEBI's insider trading regulations. The window will remain shut for all designated persons and their immediate relatives until two calendar days after the board meeting that approves the unaudited financial results for Q1 FY27 (quarter ending 30th June 2026). The intimation was filed under Regulation 30 of SEBI LODR Regulations, 2015, and signed by Whole Time Director Kashi Nath Jha. This is a routine pre-results blackout period aimed at preventing insider trading ahead of the quarterly earnings announcement.
No direct impact on shareholders; this is a standard regulatory compliance measure. The trading window closure signals that Q1 FY27 results are expected soon, which may be relevant for investors tracking the company's earnings timeline.